MicroPort NeuroTech Limited
HKEX:2172.HK
12.6 (HKD) • At close July 3, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 176.769 | 176.769 | 204.016 | 204.314 | 358.487 | 182.722 | 312.629 | 149.671 | 336.336 | 212.283 |
| Cost of Revenue
| 46.315 | 46.315 | 56.576 | 56.659 | 85.385 | 43.521 | 69.545 | 33.294 | 88.582 | 66.414 |
| Gross Profit
| 130.454 | 130.454 | 147.439 | 147.655 | 273.102 | 139.201 | 243.084 | 116.376 | 247.754 | 145.869 |
| Gross Profit Ratio
| 0.738 | 0.738 | 0.723 | 0.723 | 0.762 | 0.762 | 0.778 | 0.778 | 0.737 | 0.687 |
| Reseach & Development Expenses
| 24.069 | 24.069 | 24.161 | 24.196 | 78.855 | 47.68 | 88.327 | 42.286 | 72.997 | 50.685 |
| General & Administrative Expenses
| 13.536 | 13.536 | 14.374 | 14.395 | 0 | 13.936 | 0 | 14.099 | 0 | 0 |
| Selling & Marketing Expenses
| 38.177 | 38.177 | 28.046 | 28.087 | 0 | 27.336 | 0 | 27.973 | 0 | 0 |
| SG&A
| 51.712 | 51.712 | 42.42 | 42.482 | 80.973 | 41.272 | 87.881 | 42.073 | 87.687 | 67.458 |
| Other Expenses
| -17.491 | -17.491 | -10.345 | -10.36 | 0 | -18.377 | 0 | -9.104 | 0 | -1.875 |
| Operating Expenses
| 58.29 | 58.29 | 56.236 | 56.318 | 159.827 | 70.575 | 176.208 | 75.256 | 160.684 | 120.017 |
| Operating Income
| 72.164 | 72.164 | 91.203 | 91.336 | 113.275 | 68.626 | 66.876 | 41.12 | 87.07 | 25.852 |
| Operating Income Ratio
| 0.408 | 0.408 | 0.447 | 0.447 | 0.316 | 0.376 | 0.214 | 0.275 | 0.259 | 0.122 |
| Total Other Income Expenses Net
| -6.276 | -6.276 | -5.766 | -5.774 | -9.907 | -21.883 | 16.964 | -6.946 | 9.665 | -104.055 |
| Income Before Tax
| 65.888 | 65.888 | 85.437 | 85.562 | 103.367 | 46.742 | 83.84 | 34.174 | 96.735 | -78.203 |
| Income Before Tax Ratio
| 0.373 | 0.373 | 0.419 | 0.419 | 0.288 | 0.256 | 0.268 | 0.228 | 0.288 | -0.368 |
| Income Tax Expense
| 11.504 | 11.504 | 15.428 | 15.451 | 16.783 | 8.554 | 10.778 | 5.16 | 15.122 | 5.157 |
| Net Income
| 55.331 | 55.331 | 71.718 | 71.823 | 79.74 | 40.644 | 66.917 | 32.036 | 69.549 | -95.172 |
| Net Income Ratio
| 0.313 | 0.313 | 0.352 | 0.352 | 0.222 | 0.222 | 0.214 | 0.214 | 0.207 | -0.448 |
| EPS
| 0.096 | 0.096 | 0.13 | 0.12 | 0.136 | 0.07 | 0.111 | 0.055 | 0.123 | -0.162 |
| EPS Diluted
| 0.094 | 0.094 | 0.13 | 0.12 | 0.136 | 0.07 | 0.111 | 0.055 | 0.123 | -0.162 |
| EBITDA
| 76.017 | 70.114 | 88.277 | 88.406 | 132.28 | 79.407 | 115.465 | 39.946 | 135.078 | 42.583 |
| EBITDA Ratio
| 0.43 | 0.397 | 0.433 | 0.433 | 0.369 | 0.435 | 0.369 | 0.267 | 0.402 | 0.201 |